Vertex Pharmaceuticals (VRTX)

Net Income Growth

21.10%

TTM · Period ending:

VRTX logo

VRTX Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported21.10%
VRTX TTM Net Income YoY % (-18.60% → 21.10%)
High-resolution chart · PNG

VRTX net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-253.5798%
18.1754%
3.2732%
51.7107%
62.7113%
6.4799%
-23.8671%
-102.5641%
-40.1294%
-88%
-66.3317%
-60.5882%
-77.5862%
41.2533%
50.25%
53.9295%
53.6%
-58.2645%
-86.9159%
-44.7059%
-66.6667%
-27.3684%
-22.2857%
-553.8462%
-733.3333%
-1,050%
-1,021.0526%
58.9474%
70%
119.802%
122.619%
-35.7143%
-50%
-83.6364%
-64.7059%
-42.8571%
-25%
-22.2222%
-18.6047%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.